Portside Wealth Group »

Castle Biosciences shares owned by Portside Wealth Group

Quarter-by-quarter ownership of Castle Biosciences (CSTL) shares owned by Portside Wealth Group from 13F filings

Historical chart of Portside Wealth Group investment in Castle Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Castle Biosciences held by Portside Wealth Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Castle Biosciences by Portside Wealth Group

Quarter filed Position value Share count Share price at filing
2025-12-31 $231k 5.9k 38.90
2023-06-30 $1.6M 120k 13.72

More positions owned by Portside Wealth Group

Spdr Series Trust State Street Spd (BIL)
NVIDIA Corporation Call Option (NVDA)
Microsoft Corporation (MSFT)
Spdr Series Trust State Street Spd (SPYG)
Amazon (AMZN)
Spdr Index Shs Fds Portfolio Devlpd (SPDW)
Alphabet Cap Stk Cl A (GOOGL)
Spdr Index Shs Fds Portfolio Emg Mk (SPEM)
Spdr Series Trust State Street Spd (SPYV)
Apple (AAPL)
Visa Com Cl A (V)
Oracle Corporation (ORCL)
Alphabet Cap Stk Cl C (GOOG)
Tesla Motors (TSLA)
Eli Lilly & Co. (LLY)

View all positions for Portside Wealth Group

Top funds holding Castle Biosciences

BlackRock
Vanguard Group
Rtw Investments
Principal Financial Group
Portolan Capital Management
Dimensional Fund Advisors
Summit Partners Public Asset Management
State Street Corporation
Geode Capital Management
Palisade Capital Management
AIGH Capital Management
Allianz Asset Management
Millennium Management
Daniel D. Thurber
Nuveen

View all funds holding Castle Biosciences